Key result
The Elixir DESyne Novolimus-eluting coronary stent system is reviewed as a potentially safer alternative to first-generation drug-eluting stents, though no quantitative clinical data are reported.
The Elixir DESyne Novolimus-eluting coronary stent system is described as a potentially safer alternative to first-generation drug-eluting stents.
Answers are grounded in this paper and cite their sources.
Provides no quantitative data to guide stent selection; leaves open whether DESyne improves safety over first-generation devices.
Owing to their marked efficacy in reducing restenosis, drug-eluting stents currently represent the predominant strategy for percutaneous coronary intervention in the majority of cathertization laboratories. However, safety issues, mainly related to the presence and amount of durable polymers and/or antiproliferative drugs in the first-generation systems, may have resulted in increased rates of late and very-late stent thrombosis following implantation. The Elixir DESyne Novolimus™-eluting coronary stent system (Elixir Medical, CA, USA) comprised of a thin cobalt–chromium stent platform and the novel antiproliferative agent Novolimus, a sirolimus metabolite, released from either a durable methacrylate polymer, or bioabsorbable polylactide polymer, has recently been developed and tested as a possible safer alternative to first-generation systems. In this article, we describe the components of this novel device presenting some preliminary preclinical and clinical data of Elixir’s research program.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2010) conducted a review in Restenosis following percutaneous coronary intervention. Elixir DESyne Novolimus-eluting coronary stent system was evaluated. The Elixir DESyne Novolimus-eluting coronary stent system is reviewed as a potentially safer alternative to first-generation drug-eluting stents, though no quantitative clinical data are reported.
Synapse has enriched 10 related papers. Consider them for comparative context: